Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 435

1.

Discrepant Advanced Directives and Code Status Orders: A Preventable Medical Error.

Meisenberg B, Zaidi S, Franks L, Moller D, Mooradian D.

J Hosp Med. 2019 Jul 24;14:E1-E3. doi: 10.12788/jhm.3244. [Epub ahead of print] No abstract available.

PMID:
31339837
2.

Publisher Correction: Sarcoidosis.

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J.

Nat Rev Dis Primers. 2019 Jul 16;5(1):49. doi: 10.1038/s41572-019-0107-y.

PMID:
31311930
3.

Sarcoidosis.

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J.

Nat Rev Dis Primers. 2019 Jul 4;5(1):45. doi: 10.1038/s41572-019-0096-x. Review. Erratum in: Nat Rev Dis Primers. 2019 Jul 16;5(1):49.

PMID:
31273209
4.

Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.

Sharp M, Donnelly SC, Moller DR.

Respir Med X. 2019;1. pii: 100004. doi: 10.1016/j.yrmex.2019.100004. Epub 2019 Feb 21. No abstract available.

5.

3D vs. 4K Display System - Influence of "State-of-the-art"-Display Technique On Surgical Performance (IDOSP-Study) in minimally invasive surgery: protocol for a randomized cross-over trial.

Wahba R, Datta RR, Hedergott A, Bußhoff J, Bruns T, Kleinert R, Dieplinger G, Fuchs H, Giezelt C, Möller D, Hellmich M, Bruns CJ, Stippel DL.

Trials. 2019 May 28;20(1):299. doi: 10.1186/s13063-019-3330-7.

6.

Identification of crucial bottlenecks in engineered polyketide biosynthesis.

Grote M, Kushnir S, Pryk N, Möller D, Erver J, Ismail-Ali A, Schulz F.

Org Biomol Chem. 2019 Jul 14;17(26):6374-6385. doi: 10.1039/c9ob00831d. Epub 2019 May 15.

PMID:
31090778
7.

Validation of a robust strategy for proton spot scanning for oesophageal cancer in the presence of anatomical changes.

Møller DS, Alber M, Nordsmark M, Nyeng TB, Lutz CM, Hoffmann L.

Radiother Oncol. 2019 Feb;131:174-178. doi: 10.1016/j.radonc.2018.09.018. Epub 2018 Oct 16.

PMID:
30340776
8.

Musculoskeletal Health Complaints and Corresponding Risk Factors Among Music Students: Study Process, Analysis Strategies, and Interim Results from a Prospective Cohort Study.

Ballenberger N, Möller D, Zalpour C.

Med Probl Perform Art. 2018 Sep;33(3):166-174. doi: 10.21091/mppa.2018.3023.

PMID:
30204822
9.

Potential Relevance of Altered Muscle Activity and Fatigue in the Development of Performance-Related Musculoskeletal Injuries in High String Musicians.

Möller D, Ballenberger N, Ackermann B, Zalpour C.

Med Probl Perform Art. 2018 Sep;33(3):147-155. doi: 10.21091/mppa.2018.3021.

PMID:
30204820
10.

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP.

JAMA Neurol. 2018 Dec 1;75(12):1546-1553. doi: 10.1001/jamaneurol.2018.2295.

PMID:
30167654
11.

Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.

Jensen MF, Hoffmann L, Petersen JBB, Møller DS, Alber M.

Med Phys. 2018 Oct;45(10):4355-4363. doi: 10.1002/mp.13139. Epub 2018 Sep 6.

PMID:
30129041
12.

Replica-Based Protein Structure Sampling Methods: Compromising between Explicit and Implicit Solvents.

Kulke M, Geist N, Möller D, Langel W.

J Phys Chem B. 2018 Jul 26;122(29):7295-7307. doi: 10.1021/acs.jpcb.8b05178. Epub 2018 Jul 17.

PMID:
29966412
13.

Flexible enzymatic activation of artificial polyketide extender units by Streptomyces cinnamonensis into the monensin biosynthetic pathway.

Möller D, Kushnir S, Grote M, Ismail-Ali A, Koopmans KRM, Calo F, Heinrich S, Diehl B, Schulz F.

Lett Appl Microbiol. 2018 Sep;67(3):226-234. doi: 10.1111/lam.13039. Epub 2018 Jul 18.

PMID:
29927502
14.

National Surgical Quality Improvement Program: What Can Anesthesiologists Learn From Surgical Outcomes?

Moller DH, Gan TJ.

Anesth Analg. 2018 Jul;127(1):15-17. doi: 10.1213/ANE.0000000000003411. No abstract available.

PMID:
29912055
15.

The German version of the musculoskeletal pain intensity and interference questionnaire for musicians (MPIIQM-G): Translation and validation in professional orchestral musicians.

Möller D, Ballenberger N, Zalpour C.

Musculoskelet Sci Pract. 2018 Oct;37:1-7. doi: 10.1016/j.msksp.2018.05.005. Epub 2018 May 31.

PMID:
29879488
16.

Predictors of response to combined wake and light therapy in treatment-resistant inpatients with depression.

Kragh M, Larsen ER, Martiny K, Møller DN, Wihlborg CS, Lindhardt T, Videbech P.

Chronobiol Int. 2018 Sep;35(9):1209-1220. doi: 10.1080/07420528.2018.1468341. Epub 2018 May 11.

PMID:
29750548
17.

Totally Laparoscopic versus Open Gastrectomy for Gastric Cancer: a Matched Pair Analysis.

Ludwig K, Schneider-Koriath S, Scharlau U, Steffen H, Möller D, Bernhardt J.

Zentralbl Chir. 2018 Apr;143(2):145-154. doi: 10.1055/a-0586-9275. Epub 2018 May 2.

PMID:
29719906
18.

Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.

Hövelmann U, Bysted BV, Mouritzen U, Macchi F, Lamers D, Kronshage B, Møller DV, Heise T.

Diabetes Care. 2018 Mar;41(3):531-537. doi: 10.2337/dc17-1402. Epub 2017 Dec 22.

PMID:
29273578
19.

Systematic intrafraction shifts of mediastinal lymph node targets between setup imaging and radiation treatment delivery in lung cancer patients.

Schmidt ML, Hoffmann L, Møller DS, Knap MM, Rasmussen TR, Folkersen BH, Poulsen PR.

Radiother Oncol. 2018 Feb;126(2):318-324. doi: 10.1016/j.radonc.2017.11.030. Epub 2017 Dec 16.

PMID:
29258694
20.

Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.

Cooke G, Kamal I, Strengert M, Hams E, Mawhinney L, Tynan A, O'Reilly C, O'Dwyer DN, Kunkel SL, Knaus UG, Shields DC, Moller DR, Bowie AG, Fallon PG, Hogaboam CM, Armstrong ME, Donnelly SC.

QJM. 2018 Apr 1;111(4):217-224. doi: 10.1093/qjmed/hcx243.

21.

Time and dose-related changes in lung perfusion after definitive radiotherapy for NSCLC.

Farr KP, Khalil AA, Møller DS, Bluhme H, Kramer S, Morsing A, Grau C.

Radiother Oncol. 2018 Feb;126(2):307-311. doi: 10.1016/j.radonc.2017.11.008. Epub 2017 Dec 1.

PMID:
29203289
22.

Structure-Based Design and Discovery of New M2 Receptor Agonists.

Fish I, Stößel A, Eitel K, Valant C, Albold S, Huebner H, Möller D, Clark MJ, Sunahara RK, Christopoulos A, Shoichet BK, Gmeiner P.

J Med Chem. 2017 Nov 22;60(22):9239-9250. doi: 10.1021/acs.jmedchem.7b01113. Epub 2017 Nov 13.

23.

[Surgical management for early stage gastric cancer].

Ludwig K, Möller D, Bernhardt J.

Chirurg. 2018 May;89(5):347-357. doi: 10.1007/s00104-017-0541-x. German.

PMID:
29075796
24.

Genetic, Immunologic, and Environmental Basis of Sarcoidosis.

Moller DR, Rybicki BA, Hamzeh NY, Montgomery CG, Chen ES, Drake W, Fontenot AP.

Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S429-S436. doi: 10.1513/AnnalsATS.201707-565OT. Review.

25.

Visualization of ligand-induced dopamine D2S and D2L receptor internalization by TIRF microscopy.

Tabor A, Möller D, Hübner H, Kornhuber J, Gmeiner P.

Sci Rep. 2017 Sep 7;7(1):10894. doi: 10.1038/s41598-017-11436-1.

26.

β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation.

Männel B, Hübner H, Möller D, Gmeiner P.

Bioorg Med Chem. 2017 Oct 15;25(20):5613-5628. doi: 10.1016/j.bmc.2017.08.037. Epub 2017 Aug 24.

PMID:
28870802
27.

[Implementation of the Internet-Based Self-Management Program "moodgym" in Patients with Depressive Disorders in Inpatient Clinical Settings - Patient and Expert Perspectives].

Dorow M, Stein J, Förster F, Löbner M, Franz M, Günther R, Schröder R, Sommer D, Möller D, Dekoj MC, Becker T, Riedel-Heller SG.

Psychiatr Prax. 2018 Jul;45(5):256-262. doi: 10.1055/s-0043-117049. Epub 2017 Aug 29. German.

PMID:
28851000
28.

Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library.

Männel B, Jaiteh M, Zeifman A, Randakova A, Möller D, Hübner H, Gmeiner P, Carlsson J.

ACS Chem Biol. 2017 Oct 20;12(10):2652-2661. doi: 10.1021/acschembio.7b00493. Epub 2017 Sep 19.

PMID:
28846380
29.

Etiology and Immunopathogenesis of Sarcoidosis: Novel Insights.

Beijer E, Veltkamp M, Meek B, Moller DR.

Semin Respir Crit Care Med. 2017 Aug;38(4):404-416. doi: 10.1055/s-0037-1603087. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750457
30.

Molecular dynamics simulations and in vitro analysis of the CRMP2 thiol switch.

Möller D, Gellert M, Langel W, Lillig CH.

Mol Biosyst. 2017 Aug 22;13(9):1744-1753. doi: 10.1039/c7mb00160f.

PMID:
28726921
31.

Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.

Møller DS, Nielsen TB, Brink C, Hoffmann L, Lutz CM, Drøgemüller Lund M, Hansen O, Schytte T, Khalil AA, Knap MM, Nyhus CH, Ottosson W, Sibolt P, Borissova S, Josipovic M, Persson G, Appelt AL.

Radiother Oncol. 2017 Aug;124(2):311-317. doi: 10.1016/j.radonc.2017.06.022. Epub 2017 Jul 5.

32.

Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin.

Frederiksen AS, Albertsen AE, Christesen AMS, Vinter N, Frost L, Møller DS.

Europace. 2018 Jul 1;20(7):1078-1085. doi: 10.1093/europace/eux188.

PMID:
28655151
33.

Elucidation of the Catalytic Mechanism of a Miniature Zinc Finger Hydrolase.

Ganguly A, Luong TQ, Brylski O, Dirkmann M, Möller D, Ebbinghaus S, Schulz F, Winter R, Sanchez-Garcia E, Thiel W.

J Phys Chem B. 2017 Jul 6;121(26):6390-6398. doi: 10.1021/acs.jpcb.7b05027. Epub 2017 Jun 24.

PMID:
28648071
34.

Distress in Caregivers Accompanying Patients to an Emergency Department: A Scoping Review.

Ringer T, Moller D, Mutsaers A.

J Emerg Med. 2017 Oct;53(4):493-508. doi: 10.1016/j.jemermed.2017.03.028. Epub 2017 May 9. Review.

PMID:
28499745
35.

Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D2R Agonists.

Männel B, Dengler D, Shonberg J, Hübner H, Möller D, Gmeiner P.

J Med Chem. 2017 Jun 8;60(11):4693-4713. doi: 10.1021/acs.jmedchem.7b00363. Epub 2017 May 18.

PMID:
28489379
36.

Wake and light therapy for moderate-to-severe depression - a randomized controlled trial.

Kragh M, Martiny K, Videbech P, Møller DN, Wihlborg CS, Lindhardt T, Larsen ER.

Acta Psychiatr Scand. 2017 Dec;136(6):559-570. doi: 10.1111/acps.12741. Epub 2017 Apr 19.

PMID:
28422269
37.

Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.

Kazda CM, Ding Y, Kelly RP, Garhyan P, Shi C, Lim CN, Fu H, Watson DE, Lewin AJ, Landschulz WH, Deeg MA, Moller DE, Hardy TA.

Diabetes Care. 2017 Jun;40(6):808. doi: 10.2337/dc17-er06. Epub 2017 Apr 18. No abstract available.

38.

Reliability of dose volume constraint inference from clinical data.

Lutz CM, Møller DS, Hoffmann L, Knap MM, Alber M.

Phys Med Biol. 2017 Apr 21;62(8):3250-3262. doi: 10.1088/1361-6560/aa63d4.

PMID:
28350545
39.

Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure.

Möller D, Banerjee A, Uzuneser TC, Skultety M, Huth T, Plouffe B, Hübner H, Alzheimer C, Friedland K, Müller CP, Bouvier M, Gmeiner P.

J Med Chem. 2017 Apr 13;60(7):2908-2929. doi: 10.1021/acs.jmedchem.6b01857. Epub 2017 Mar 22.

PMID:
28248104
40.

Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.

Kruse MJ, Kovell L, Kasper EK, Pomper MG, Moller DR, Solnes L, Chen ES, Schindler TH.

JACC Cardiovasc Imaging. 2017 Feb;10(2):157-167. doi: 10.1016/j.jcmg.2016.09.023. Epub 2017 Jan 18.

41.

Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage.

Hoffmann L, Alber M, Jensen MF, Holt MI, Møller DS.

Radiother Oncol. 2017 Mar;122(3):400-405. doi: 10.1016/j.radonc.2016.12.018. Epub 2016 Dec 31.

PMID:
28043645
42.

Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.

Kazda CM, Ding Y, Kelly RP, Garhyan P, Shi C, Lim CN, Fu H, Watson DE, Lewin AJ, Landschulz WH, Deeg MA, Moller DE, Hardy TA.

Diabetes Care. 2016 Nov;39(11):e199-e200. No abstract available.

PMID:
27926898
43.

Experiences of wake and light therapy in patients with depression: A qualitative study.

Kragh M, Møller DN, Wihlborg CS, Martiny K, Larsen ER, Videbech P, Lindhardt T.

Int J Ment Health Nurs. 2017 Apr;26(2):170-180. doi: 10.1111/inm.12264. Epub 2016 Nov 2.

PMID:
27804203
44.

Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose.

Møller DS, Holt MI, Alber M, Tvilum M, Khalil AA, Knap MM, Hoffmann L.

Radiother Oncol. 2016 Oct;121(1):32-38. doi: 10.1016/j.radonc.2016.08.019. Epub 2016 Sep 16.

PMID:
27647459
45.

Cardiac and respiration induced motion of mediastinal lymph node targets in lung cancer patients throughout the radiotherapy treatment course.

Schmidt ML, Hoffmann L, Knap MM, Rasmussen TR, Folkersen BH, Toftegaard J, Møller DS, Poulsen PR.

Radiother Oncol. 2016 Oct;121(1):52-58. doi: 10.1016/j.radonc.2016.07.015. Epub 2016 Aug 2.

PMID:
27492202
46.

Structure-guided development of heterodimer-selective GPCR ligands.

Hübner H, Schellhorn T, Gienger M, Schaab C, Kaindl J, Leeb L, Clark T, Möller D, Gmeiner P.

Nat Commun. 2016 Jul 26;7:12298. doi: 10.1038/ncomms12298.

47.

Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population.

Qvist I, Hendriks JM, Møller DS, Albertsen AE, Mogensen HM, Oddershede GD, Odgaard A, Mortensen LS, Johnsen SP, Frost L.

Open Heart. 2016 Jan 13;3(1):e000335. doi: 10.1136/openhrt-2015-000335. eCollection 2016.

48.

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.

Kazda CM, Ding Y, Kelly RP, Garhyan P, Shi C, Lim CN, Fu H, Watson DE, Lewin AJ, Landschulz WH, Deeg MA, Moller DE, Hardy TA.

Diabetes Care. 2016 Jul;39(7):1241-9. doi: 10.2337/dc15-1643. Epub 2015 Dec 17. Erratum in: Diabetes Care. 2017 Jun;40(6):808.

PMID:
26681715
49.

[Effects of Reactive Jump Training in Handball Players Regarding Jump Height and Power Development in the Triceps Surae Muscle].

Rensing N, Westermann A, Möller D, von Piekartz H.

Sportverletz Sportschaden. 2015 Dec;29(4):236-43. doi: 10.1055/s-0041-106947. Epub 2015 Nov 18. German.

PMID:
26579625
50.

Neurogenesis in sea urchin embryos and the diversity of deuterostome neurogenic mechanisms.

Garner S, Zysk I, Byrne G, Kramer M, Moller D, Taylor V, Burke RD.

Development. 2016 Jan 15;143(2):286-97. doi: 10.1242/dev.124503. Epub 2015 Oct 28.

Supplemental Content

Loading ...
Support Center